Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Selatogrel in Hepatic Impairment
NCT04406896Phase 1Completed
- Sponsor
- Viatris
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of selatogrel in acute myocardial infarction (AMI) (3 arms), sponsored by Viatris. Primary endpoints: Maximum Plasma Concentration at Day 3, Time to Reach Cmax at Day 3 and 6 more. Started Jul 2020; status: completed.
02
Drugs
selatogrel
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT04406896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04406896.